Epigenetic alterations, like DNA methylation, in the promoter regions of tumor/metastasis suppressor genes, such as SOX17, BRMS1, and CST6 in EpCAM+ CTCs isolated from individuals with BC, are known to be correlated with enhanced tumor metastasis and poor prognosis [78]. Here, CST6 is linked to neoplasm.